Report cover image

Alpha Emitter Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War

Publisher Prodture
Published Oct 02, 2024
Length 120 Pages
SKU # PROD19315295

Description

Alpha Emitter Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War


The global alpha emitter market is expected to grow at a CAGR of around 14.2% during 2025-2034. This report on global alpha emitter market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global alpha emitter market by segmenting the market based on type of radionuclide, medical application, end user, and region. Also, detailed profiles of companies operating in the alpha emitter market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

● Increased Awareness About the Potential Benefits of Targeted Alpha Therapy
● Increasing Number of Patients with Cardiac and Cancer Ailments


Market Challenges

● Stringent Regulatory Framework and Reimbursement Issues
● Need for High Capital Investment


Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Type of Radionuclide

● Astatine
● Radium
● Actinium
● Lead
● Bismuth
● Others

Market by Medical Application

● Prostate Cancer
● Bone Metastasis
● Ovarian Cancer
● Pancreatic Cancer
● Endocrine Tumors
● Others

Market by End User

● Hospitals
● Medical Research Institutions
● Others

Market by Region

● Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
● North America
United States
Canada
● Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
● Latin America
Mexico
Brazil
Argentina
Rest of Latin America
● Middle East & Africa
Saudi Arabia
Turkey
Iran
Rest of Middle East & Africa

Table of Contents

120 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Alpha Emitter Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Alpha Emitter Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Alpha Emitter Market by Type of Radionuclide
5.1. Introduction
5.2. Astatine
5.3. Radium
5.4. Actinium
5.5. Lead
5.6. Bismuth
5.7. Others
6. Global Alpha Emitter Market by Medical Application
6.1. Introduction
6.2. Prostate Cancer
6.3. Bone Metastasis
6.4. Ovarian Cancer
6.5. Pancreatic Cancer
6.6. Endocrine Tumors
6.7. Others
7. Global Alpha Emitter Market by End User
7.1. Introduction
7.2. Hospitals
7.3. Medical Research Institutions
7.4. Others
8. Global Alpha Emitter Market by Region
8.1. Introduction
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Netherlands
8.2.8. Rest of the Europe
8.3. North America
8.3.1. United States
8.3.2. Canada
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. Indonesia
8.4.7. Rest of the Asia Pacific
8.5. Latin America
8.5.1. Mexico
8.5.2. Brazil
8.5.3. Argentina
8.5.4. Rest of Latin America
8.6. Middle East & Africa
8.6.1. Saudi Arabia
8.6.2. Turkey
8.6.3. Iran
8.6.4. United Arab Emirates
8.6.5. Rest of Middle East & Africa
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Company Profiles
12.2.1. Actinium Pharmaceuticals, Inc.
12.2.2. Alpha Tau Medical
12.2.3. Bayer AG
12.2.4. Fusion Pharma
12.2.5. IBA Group
12.2.6. Lantheus Medical Imaging, Inc.
12.2.7. NTP Radiosotopes SOC Ltd.
12.2.8. RadioMedix, Inc.
12.2.9. Siemens Healthineers
12.2.10. Telix Pharmaceuticals Ltd.
12.2.11. Triad Isotopes, Inc
List of Figures
Figure 1: Global Alpha Emitter Market (in US$ Million), 2020-2024
Figure 2: Global Alpha Emitter Market by Type of Radionuclide, 2024
Figure 3: Global Alpha Emitter Market by Medical Application, 2024
Figure 4: Global Alpha Emitter Market by End User, 2024
Figure 5: Global Alpha Emitter Market by Region, 2024
Figure 6: Global Alpha Emitter Market (in US$ Million), 2025-2034
Figure 7: Global Alpha Emitter Market by Type of Radionuclide (in %), 2024 & 2034
Figure 8: Global Astatine Alpha Emitter Market (in US$ Million), 2020-2024
Figure 9: Global Astatine Alpha Emitter Market (in US$ Million), 2025-2034
Figure 10: Global Radium Alpha Emitter Market (in US$ Million), 2020-2024
Figure 11: Global Radium Alpha Emitter Market (in US$ Million), 2025-2034
Figure 12: Global Actinium Alpha Emitter Market (in US$ Million), 2020-2024
Figure 13: Global Actinium Alpha Emitter Market (in US$ Million), 2025-2034
Figure 14: Global Lead Alpha Emitter Market (in US$ Million), 2020-2024
Figure 15: Global Lead Alpha Emitter Market (in US$ Million), 2025-2034
Figure 16: Global Bismuth Alpha Emitter Market (in US$ Million), 2020-2024
Figure 17: Global Bismuth Alpha Emitter Market (in US$ Million), 2025-2034
Figure 18: Global Other Type of Radionuclides Alpha Emitter Market (in US$ Million), 2020-2024
Figure 19: Global Other Type of Radionuclides Alpha Emitter Market (in US$ Million), 2025-2034
Figure 20: Global Alpha Emitter Market by Medical Application (in %), 2024 & 2034
Figure 21: Global Prostate Cancer Alpha Emitter Market (in US$ Million), 2020-2024
Figure 22: Global Prostate Cancer Alpha Emitter Market (in US$ Million), 2025-2034
Figure 23: Global Bone Metastasis Alpha Emitter Market (in US$ Million), 2020-2024
Figure 24: Global Bone Metastasis Alpha Emitter Market (in US$ Million), 2025-2034
Figure 25: Global Ovarian Cancer Alpha Emitter Market (in US$ Million), 2020-2024
Figure 26: Global Ovarian Cancer Alpha Emitter Market (in US$ Million), 2025-2034
Figure 27: Global Pancreatic Cancer Alpha Emitter Market (in US$ Million), 2020-2024
Figure 28: Global Pancreatic Cancer Alpha Emitter Market (in US$ Million), 2025-2034
Figure 29: Global Endocrine Tumors Alpha Emitter Market (in US$ Million), 2020-2024
Figure 30: Global Endocrine Tumors Alpha Emitter Market (in US$ Million), 2025-2034
Figure 31: Global Other Medical Applications Alpha Emitter Market (in US$ Million), 2020-2024
Figure 32: Global Other Medical Applications Alpha Emitter Market (in US$ Million), 2025-2034
Figure 33: Global Alpha Emitter Market by End User (in %), 2024 & 2034
Figure 34: Global Hospitals Alpha Emitter Market (in US$ Million), 2020-2024
Figure 35: Global Hospitals Alpha Emitter Market (in US$ Million), 2025-2034
Figure 36: Global Medical Research Institutions Alpha Emitter Market (in US$ Million), 2020-2024
Figure 37: Global Medical Research Institutions Alpha Emitter Market (in US$ Million), 2025-2034
Figure 38: Global Other End Users Alpha Emitter Market (in US$ Million), 2020-2024
Figure 39: Global Other End Users Alpha Emitter Market (in US$ Million), 2025-2034
Figure 40: Global Alpha Emitter Market by Region (in %), 2024 & 2034
Figure 41: Europe Alpha Emitter Market (in US$ Million), 2020-2024
Figure 42: Europe Alpha Emitter Market (in US$ Million), 2025-2034
Figure 43: Europe Alpha Emitter Market by Country (in %), 2024 & 2034
Figure 44: Germany Alpha Emitter Market (in US$ Million), 2020-2034
Figure 45: United Kingdom Alpha Emitter Market (in US$ Million), 2020-2034
Figure 46: France Alpha Emitter Market (in US$ Million), 2020-2034
Figure 47: Italy Alpha Emitter Market (in US$ Million), 2020-2034
Figure 48: Spain Alpha Emitter Market (in US$ Million), 2020-2034
Figure 49: Russia Alpha Emitter Market (in US$ Million), 2020-2034
Figure 50: Netherlands Alpha Emitter Market (in US$ Million), 2020-2034
Figure 51: North America Alpha Emitter Market (in US$ Million), 2020-2024
Figure 52: North America Alpha Emitter Market (in US$ Million), 2025-2034
Figure 53: North America Alpha Emitter Market by Country (in %), 2024 & 2034
Figure 54: United States Alpha Emitter Market (in US$ Million), 2020-2034
Figure 55: Canada Alpha Emitter Market (in US$ Million), 2020-2034
Figure 56: Asia Pacific Alpha Emitter Market (in US$ Million), 2020-2024
Figure 57: Asia Pacific Alpha Emitter Market (in US$ Million), 2025-2034
Figure 58: Asia Pacific Alpha Emitter Market by Country (in %), 2024 & 2034
Figure 59: China Alpha Emitter Market (in US$ Million), 2020-2034
Figure 60: Japan Alpha Emitter Market (in US$ Million), 2020-2034
Figure 61: India Alpha Emitter Market (in US$ Million), 2020-2034
Figure 62: South Korea Alpha Emitter Market (in US$ Million), 2020-2034
Figure 63: Australia Alpha Emitter Market (in US$ Million), 2020-2034
Figure 64: Indonesia Alpha Emitter Market (in US$ Million), 2020-2034
Figure 65: Latin America Alpha Emitter Market (in US$ Million), 2020-2024
Figure 66: Latin America Alpha Emitter Market (in US$ Million), 2025-2034
Figure 67: Latin America Alpha Emitter Market by Country (in %), 2024 & 2034
Figure 68: Mexico Alpha Emitter Market (in US$ Million), 2020-2034
Figure 69: Brazil Alpha Emitter Market (in US$ Million), 2020-2034
Figure 70: Argentina Alpha Emitter Market (in US$ Million), 2020-2034
Figure 71: Middle East & Africa Alpha Emitter Market (in US$ Million), 2020-2024
Figure 72: Middle East & Africa Alpha Emitter Market (in US$ Million), 2025-2034
Figure 73: Middle East & Africa Alpha Emitter Market by Country (in %), 2024 & 2034
Figure 74: Saudi Arabia Alpha Emitter Market (in US$ Million), 2020-2034
Figure 75: Turkey Alpha Emitter Market (in US$ Million), 2020-2034
Figure 76: Iran Alpha Emitter Market (in US$ Million), 2020-2034
Figure 77: UAE Alpha Emitter Market (in US$ Million), 2020-2034
Figure 78: Market Value Chain
List of Tables
Table 1: Global Alpha Emitter Market Portraiture
Table 2: Global Alpha Emitter Market by Type of Radionuclide (in US$ Million), 2024 & 2034
Table 3: Global Alpha Emitter Market by Medical Application (in US$ Million), 2024 & 2034
Table 4: Global Alpha Emitter Market by End User (in US$ Million), 2024 & 2034
Table 5: Global Alpha Emitter Market by Region (in US$ Million), 2024 & 2034
Table 6: Europe Alpha Emitter Market by Country (in US$ Million), 2024 & 2034
Table 7: North America Alpha Emitter Market by Country (in US$ Million), 2024 & 2034
Table 8: Asia Pacific Alpha Emitter Market by Country (in US$ Million), 2024 & 2034
Table 9: Latin America Alpha Emitter Market by Country (in US$ Million), 2024 & 2034
Table 10: Middle East & Africa Alpha Emitter Market by Country (in US$ Million),
2024 & 2034
Table 11: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us